Ceigall India Limited announces audited results and resignation of director
Ceigall India · Construction
Key highlights
- The Board approved audited standalone and consolidated results for Q4 and FY ended March 31, 2026, audited by M/s B. D. Bansal & Co with an unmodified opinion.
- Dividend proposed for FY 2025-26 at 10%, i.e., Rs. 0.50 per equity share of face value Rs. 5 each, subject to shareholders' approval at AGM.
- Mr. Chitwon Wason resigned as Whole-Time Director/Director effective from closure of business hours on May 20, 2026; resignation letter attached.
Why it's rated major development: the year-on-year change is 71% (50% or more)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Financial Results For March 31, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Ceigall India
- Capex / expansionMajor developmentCeigall India Q2 FY27 consolidated PAT up 64.1% YoY to INR 922 million
- Fundraise / allotmentMajor developmentCeigall India approves Q2 results, up to Rs. 1000 Crores fundraise, subsidiary sale offer
- Fundraise / allotmentMajor developmentCeigall India Sep-26 quarter profit Rs 921.67 mn; board approves Rs 1000 crore raise
- Fundraise / allotmentNotableCeigall India: Q2 results, Rs. 1000 crore fund raise plan, subsidiary sale offer
- Order winNotableCeigall India Limited receives LoI for Rs. 5300 crore transmission project from RECPDCL
Other financial results filings this fortnight
- Kovai Medical Center Q2 profit ₹7,696.61 lakhs vs ₹5,886.14 lakhs a year earlier
- Siddhika Coatings Limited approves joint venture and announces H1 FY 2026 financials
- Financial resultsBrooks LaboratoriesBrooks Laboratories Limited announces Q2 and H1 FY2026 unaudited financial results
- Financial resultsBrooks LaboratoriesBrooks Laboratories Limited announces Q2 and H1 FY2027 financial results and divestment
- NHC Foods reports Sept 2026 quarter results, 99.98% firm stake, two appointments
- Spectrum Electrical Industries Ltd approves Q2 & H1 results for period ended September 30, 2026
Potential multibaggers · Q2 FY27
Potential multibaggers in Construction
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.
